课题基金 / 基金详情

Research of transporter-adaptor network as target of drug effect and toxicity

Research of transporter-adaptor network as target of drug effect and toxicity
转运蛋白-适配器网络作为药效和毒性靶标的研究
批准号:
20390047
负责人:
KATO Yukio
金额:
$12.31万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

KATO Yukio的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Transporters are the membrane proteins involved in permeation of drug molecules across plasma membranes. Although they are assumed to play fundamental roles in drug absorption and disposition, little information is available on their direct association with drug efficacy and toxicity. Therefore, the aim of the present study was to clarify pharmacokinetic, pharmacodynamic and toxicodynamic roles of transporters by focusing on their adaptor proteins which have already been clarified by our previous studies. As the final results of this grant, we have clarified (i) the roles of carnitine/organic cation transporters (OCTNs) in drug disposition and efficacy in small intestine, liver, kidney and heart, (ii) the roles of influx and efflux transporters in gastrointestinal drug absorption, and (iii) direct interaction and regulation of three intestinal influx transporters by an adaptor protein PDZK1.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pharnweokineties and hepatic uptake of eltromhopag, a novel platelet-increasing agent.
新型血小板增加剂 eltromhopag 的药物动力学和肝脏摄取。
DOI: --
发表时间: 2011
期刊: Drug ,Mekab Dispos
影响因子: --
作者: [Takcuchi K, Sugiura T, Umeda S, Matsuhara K, Horikawa M, Nakamichi N.Silver DL., Ishiwata N.Kato Y]
通讯作者: Ishiwata N.Kato Y
Molecular mechanisms of biliary excretion of celditoren and the effeets of cefdit oren on the expression levels of henatic transnorters.
celditoren 胆汁排泄的分子机制以及 cefdit oren 对 hematic transnorters 表达水平的影响。
DOI: --
发表时间: 2010
期刊: Drug Metab Pharmacokinet
影响因子: --
作者: [Meng Q, Liu Q, Wang C, Sun H.Kaku T.Kato Y.LiuK]
通讯作者: Sun H.Kaku T.Kato Y.LiuK
Involvement of multidrug resistance-associated protein 2 (Abcc2) in molecular weight-dependent biliary excretion of β-lactam antibiotics.
多药耐药相关蛋白 2 (Abcc2) 参与 β-内酰胺抗生素分子量依赖性胆汁排泄。
DOI: --
发表时间: 2008
期刊: Drug Metab Dispos 36(6)
影响因子: --
作者: [Kato Y, Takahara S, Kato S, Kubo Y, Sai Y, Tamai I, Yabuuchi H, Tsuji A.]
通讯作者: Tsuji A.
PDZK1 regulates two intestinal solute carriers (Slcl5al and Slc22a5) in mice.
PDZK1 调节小鼠体内的两种肠道溶质载体(Slcl5a1 和 Slc22a5)。
DOI: --
发表时间: 2008
期刊: Drug Me tab Dispos 36(6)
影响因子: --
作者: [Sugiura T, Kato Y, Wakayama T, Silver DL, Kubo Y, Iseki S, Tsuji A.]
通讯作者: Tsuji A.
48
    Transdermal drug delivery targeted to xenobiotics ABC transporters expressed in the skin
    • 批准号:
      25670011
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2013
    • 负责人:
      KATO Yukio
    • 依托单位:
    The development of culture surfaces expressing functional groups that enhance isolation, proliferation and differentiation of mesenchymal stem cells.
    • 批准号:
      24659876
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2012
    • 负责人:
      KATO Yukio
    • 依托单位:
    Development of triple-target antitumor drugs recognized by oligopeptide transporters
    • 批准号:
      23659019
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      KATO Yukio
    • 依托单位:
    Digital Archives and Early Modern English Theatre: The Network of Playhouses, Players, and Printing-houses
    • 批准号:
      23320059
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.48万
    • 财政年份:
      2011
    • 负责人:
      KATO Yukio
    • 依托单位:
    海外基金